Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya

Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya

Abstract Increased immune evasion by emerging and highly mutated SARS-CoV-2 variants is a key challenge to the control of COVID-19. The majority of these mutations mainly target the spike protein, allowing the new variants to escape the immunity previously raised by vaccination and/or infection by e...

Full description

Bibliographic Details
Main Authors: Doreen Lugano, Bernadette Kutima, Makobu Kimani, Antipa Sigilai, John Gitonga, Angela Karani, Donald Akech, Boniface Karia, Abdhalah K. Ziraba, Angela Maina, Arnold Lambisia, Donwilliams Omuoyo, Daisy Mugo, Ruth Lucinde, Sharon Owuor, Gloria Konyino, Joseph Newman, Dalan Bailey, Eunice Nduati, George Githinji, Charles N. Agoti, Philip Bejon, J. Anthony G. Scott, Ambrose Agweyu, Wangeci Kagucia, George M. Warimwe, Charles Sande, Lynette I. Ochola-Oyier, James Nyagwange
Format: Article
Language:English
Published: BMC 2024-12-01
Series:BMC Infectious Diseases
Subjects:
SARS-CoV-2 variants
Vaccination
Neutralization
Population immunity
Online Access:https://doi.org/10.1186/s12879-024-10367-3

Internet

https://doi.org/10.1186/s12879-024-10367-3

Similar Items